Carregant...
A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer
BACKGROUND: Pathologic variables that characterize response of prostate carcinoma to current neoadjuvant therapy have not been characterized in detail. This study reports (1) the histological features of prostate cancer treated with abiraterone and enzalutamide and inter-pathologist variance in iden...
Guardat en:
| Publicat a: | Prostate |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4988926/ https://ncbi.nlm.nih.gov/pubmed/27273062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23215 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|